InspireMD, Inc. Series B Warrants
NSPRZ
NSPRZ was delisted on the 14th of March, 2022.
2 hedge funds and large institutions have $5K invested in InspireMD, Inc. Series B Warrants in 2021 Q4 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 2 → 2 (0)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
17% less capital invested
Capital invested by funds: $6K → $5K (-$1K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$1.82K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$1.13K |
NSPRZ Hedge Fund Activity: Q4 2021 in Review
2 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in InspireMD, Inc. Series B Warrants (NSPRZ) for Q4 2021, worth a combined $5K — down 17% from $6K a quarter earlier.
Fund positioning in NSPRZ was balanced in Q4 2021: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was UBS Group, adding an estimated $1.82K. The largest seller was Virtu Financial, cutting an estimated $1.13K.
- 2 institutional investors held InspireMD, Inc. Series B Warrants (NSPRZ) as of Q4 2021, unchanged from Q3 2021.
- Funds reported $5K of InspireMD, Inc. Series B Warrants stock for Q4 2021, down 17% quarter-over-quarter.
- 0 funds opened new InspireMD, Inc. Series B Warrants positions in Q4 2021 and 0 closed out.
- The largest InspireMD, Inc. Series B Warrants buyer in Q4 2021 was UBS Group, an estimated $1.82K added.
- The largest InspireMD, Inc. Series B Warrants seller in Q4 2021 was Virtu Financial, an estimated $1.13K sold.
Based on aggregated 13F filings for Q4 2021.